Literature DB >> 25655049

Expression of RGC32 in human normal and preeclamptic placentas and its role in trophoblast cell invasion and migration.

Q-j Wang1, B-f Song2, Y-h Zhang3, Y-y Ma4, Q-q Shao5, J Liu6, X Qu7.   

Abstract

INTRODUCTION: Preeclampsia (PE) is a pregnancy-specific complication and it is related to insufficient extravillous trophoblast invasion. To date, the pathophysiology of PE has not yet been fully elucidated. Response gene to complement 32 (RGC32) is a novel cellular protein, and it plays important roles in the regulation of cell differentiation, angiogenesis, migration, and invasion. This study aimed to determine the RGC32 expression and function in human placentas and to explore the underlying mechanisms.
METHODS: RGC32 expression in term placentas collected after cesarean section from pregnant women with PE and normal pregnant women was determined by real-time reverse transcriptase polymerase chain reaction (RT-PCR), Western blot, and immunohistochemistry. The effects of RGC32 expression on trophoblast invasion, migration, and the underlying mechanisms were studied in HTR8/SVneo cells.
RESULTS: The messenger RNA (mRNA) and protein levels of RGC32 were significantly downregulated in preeclamptic placentas compared with normal controls (P < 0.05). RGC32 silencing significantly inhibited HTR8/SVneo cell migration and invasion (P < 0.001, respectively). These effects were associated with decreased activities and expression of matrix metalloproteinase (MMP)-2/9, and with the reduced phosphorylation level of Akt. DISCUSSION: RGC32 may play important roles in the pathophysiology of PE by directly affecting the invasion/migration of trophoblast.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Invasion; MMPs; Migration; Preeclampsia; RGC32

Mesh:

Substances:

Year:  2015        PMID: 25655049     DOI: 10.1016/j.placenta.2014.12.012

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  6 in total

1.  New insights into the roles of RGC-32.

Authors:  Qingjie Wang; Xun Qu
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

2.  Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia.

Authors:  Jennifer L Sones; Audrey A Merriam; Angelina Seffens; Dex-Ann Brown-Grant; Scott D Butler; Anna M Zhao; Xinjing Xu; Carrie J Shawber; Jennifer K Grenier; Nataki C Douglas
Journal:  FASEB J       Date:  2018-01-08       Impact factor: 5.191

3.  Primary Human Trophoblasts Mimic the Preeclampsia Phenotype after Acute Hypoxia-Reoxygenation Insult.

Authors:  Barbara Fuenzalida; Sampada Kallol; Jonas Zaugg; Martin Mueller; Hiten D Mistry; Jaime Gutierrez; Andrea Leiva; Christiane Albrecht
Journal:  Cells       Date:  2022-06-11       Impact factor: 7.666

Review 4.  Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders.

Authors:  Louise Fliedel; Khair Alhareth; Nathalie Mignet; Thierry Fournier; Karine Andrieux
Journal:  Biomedicines       Date:  2022-04-19

5.  Response Gene to Complement 32 Maintains Blood Pressure Homeostasis by Regulating α-Adrenergic Receptor Expression.

Authors:  Jun-Ming Tang; Ning Shi; Kun Dong; Scott A Brown; Amanda E Coleman; Matthew A Boegehold; Shi-You Chen
Journal:  Circ Res       Date:  2018-10-12       Impact factor: 17.367

Review 6.  Response Gene to Complement 32 in Vascular Diseases.

Authors:  Xiao-Bing Cui; Shi-You Chen
Journal:  Front Cardiovasc Med       Date:  2018-09-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.